Abbott

Abbott | August 02, 2016

On 8/1/2016, shares of Abbott Laboratories (NYSE:ABT) rose +1.21% in trading session and finally closed at $45.29. The company most recent volume stood at 12.15 million shares as compared to average volume of 11.07 million shares. Over the one year trading period, the stock has a high price of $51.17 and its low price is recorded at $36.00. The company has a market cap of $66.54B....

Abbott | August 02, 2016

Abbott Laboratories (ABT) : Candriam Luxembourg S.c.a. scooped up 564,323 additional shares in Abbott Laboratories during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 26, 2016....

Healthcare IT News | April 19, 2018

Abbott released its second and final round of planned cybersecurity updates to its pacemakers, programmers and remote monitoring systems to fix severe cybersecurity flaws in the devices. The patch will update the battery performance alert, allowing the device to monitor for abnormal battery behavior and automatically vibrate to tell the patient when something is wrong. The planned updates began last year, and the latest firmware update was approved by the Food and Drug Administration last week. ...

MedCity News | January 13, 2020

Healthcare analytics company Arcadia raised $29.5 million in new funding. The growth capital round was led by Cigna Ventures, with participation from past investors. Burlington, Massachusetts-based Arcadia integrates with more than 40 different electronic health record companies. It aggregates and analyzes records data to help hospitals and accountable care organizations meet metrics for value-based care. The company also develops tools to identify gaps in patient care and find ways to improve o...